boston scientific

Insiders may buy shares of a company because they believe its stock price will move higher and want to profit from this anticipated rise. Sell-offs might provide an opportunity for insiders who have faith in a company to snatch up shares. Below are some stocks that have recently seen insider buying...

While the fate of the 2010 health care reform law may rest in the hands of the Supreme Court, the nation's focus on health care has returned for the moment. For investors, the following health care picks all pay a dividend and have seen double-digit percentage growth in their share price since the...

Here's a quick look at some of the top performing health care stocks, year to date. These stocks all have a market cap of more than $1 billion and all pay a dividend. Baxter International (NYSE: BAX) is more than 11% higher than a month ago, and more than 17% higher than a year ago. The company...

Lots more earnings are on the schedule for this week, even as the calendar page turns. Look for quarterly results to come from Exxon Mobil (NYSE: XOM), Hershey (NYSE: HSY), Kellogg (NYSE: K), MasterCard (NYSE: MA), Northrop Grumman (NYSE: NOC) and United Parcel Service (NYSE: UPS). Analysts expect...

Cooper Companies (NYSE: COO) is scheduled to report fiscal fourth-quarter 2011 results tomorrow afternoon, December 8. Its profit fell in the third quarter, breaking a streak of three consecutive quarters of year-over-year profit increases. Investors will be looking for Cooper to return to earnings...

Insiders may sell shares for any number of reasons, but there is really only one reason insiders buy shares of a company -- they believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company...

Boston Scientific Corporation (Nasdaq: BSX) has announced the FDA approval of its INCEPTA(TM), ENERGEN(TM) and PUNCTUA(TM) cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) to treat heart failure and sudden cardiac death. The new...

The earnings season ramps up this week. Tech giants Apple (NASDAQ: AAPL), Microsoft (NYSE: MSFT), Intel (NASDAQ: INTC) and IBM (NYSE: IBM) are scheduled to share their third-quarter results, as are big banks including Bank of America (NYSE: BAC), Citigroup (NYSE: C), Goldman Sachs (NYSE: GS),...

While the DJIA and S&P 500 dropped on today's opening, medical device makers MAKO Surgical (NASDAQ: MAKO) and Urologix (NYSE: ULGX) have reached new multiyear highs of $38.13 and $1.22 per share, respectively. MAKO Surgical reported last month that second-quarter revenue grew 81% year over...

Morgan Stanley has published a report on Boston Scientifics (NYSE: BSX) outlining general operating numbers for the medical device developer. In the report, Morgan Stanley wrote, "Revenue and margin uncertainty keep us from a more constructive outlook despite progress on cost initiatives and the...

Stifel Nicolaus has upgraded the following companies: Boston Scientific (NYSE: BSX) from Hold to Buy, $9 PT Forest Oil (NYSE: FST) from Hold to Buy, $34 PT